TG Therapeutics | TGTX - Equity Capital And Reserves

Stock Price
28.88
Daily Change
1.12 4.03%
Monthly
-4.81%
Yearly
-12.72%
Q1 Forecast
28.52

TG Therapeutics reported $607.22M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -2.64B 2.46B Sep/2025
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Amgen USD 9.62B 2.19B Sep/2025
Ardelyx USD 154.28M 14.75M Sep/2025
Arrowhead Research USD 568.42M 102.37M Dec/2025
Bayer EUR 29.7B 799M Sep/2025
Biogen USD 18.21B 573.5M Sep/2025
Corcept Therapeutics USD 631.9M 3.89M Sep/2025
Dynavax Technologies USD 534.14M 39.98M Sep/2025
Gilead Sciences USD 21.46B 1.78B Sep/2025
J&J USD 78.47B 0 Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
PTC Therapeutics USD -155.76M 50.79M Sep/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
TG Therapeutics USD 607.22M 330.79M Sep/2025
Vertex Pharmaceuticals USD 17.32B 143.4M Sep/2025